Literature DB >> 6329234

Female hormones reduce neutrophil responsiveness in vitro.

J P Buyon, H M Korchak, L E Rutherford, M Ganguly, G Weissmann.   

Abstract

Neutrophils were preincubated with 17 beta-estradiol and progesterone to determine the effects of these hormones on chemotactic peptide-stimulated superoxide anion (O2-) generation and degranulation. At pharmacologic levels 17 beta-estradiol was more active than progesterone with respect to inhibition of O2- generation as well as degranulation. An increase of preincubation time from 5 minutes to 25 minutes increased the percent inhibition. When 17 beta-estradiol and progesterone were combined at levels which approximate those measured during gestation, there was small but significant inhibition of O2- generation. Dexamethasone at equal molar concentration inhibited O2- generation only after 25 minutes of preincubation and at no time reached the level of inhibition attained by either of the sex hormones alone. Both estradiol and progesterone at pharmacologic levels significantly inhibited beta-glucuronidase and lysozyme release, whereas dexamethasone did not inhibit degranulation despite prolonged preincubation. Neutrophils isolated from women during various phases of the menstrual cycle and during the third trimester of pregnancy did not differ with respect to chemotactic peptide-stimulated O2- generation. These data suggest that inhibition of neutrophil responses requires the continuous presence of pharmacologic levels of estradiol and progesterone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329234     DOI: 10.1002/art.1780270604

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  25 in total

Review 1.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 2.  Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes.

Authors:  A Mancini; R Festa; V Di Donna; E Leone; G P Littarru; A Silvestrini; E Meucci; A Pontecorvi
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

Review 3.  Which gender is better positioned in the process of liver surgery? Male or female?

Authors:  Yukihiro Yokoyama; Masato Nagino; Yuji Nimura
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

Review 4.  Neuroendocrine factors alter host defense by modulating immune function.

Authors:  Cherie L Butts; Esther M Sternberg
Journal:  Cell Immunol       Date:  2008-03-07       Impact factor: 4.868

5.  Gender differences in neutrophil function and cytokine-induced neutrophil chemoattractant generation in endotoxic rats.

Authors:  J A Spitzer; P Zhang
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

6.  Inhibition of granulocyte function by steroids is not limited to corticoids. Studies with sex steroids.

Authors:  D E Hammerschmidt; A C Knabe; P T Silberstein; H R Lamche; P A Coppo
Journal:  Inflammation       Date:  1988-06       Impact factor: 4.092

7.  Neutrophil function in pregnancy and rheumatoid arthritis.

Authors:  I P Crocker; P N Baker; J Fletcher
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

Review 8.  Passively acquired autoimmunity and the maternal fetal dyad in systemic lupus erythematosus.

Authors:  J Buyon; I Szer
Journal:  Springer Semin Immunopathol       Date:  1986

9.  Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon.

Authors:  E Roilides; K Uhlig; D Venzon; P A Pizzo; T J Walsh
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

Review 10.  Infections related to the menstrual cycle. A study of five otherwise healthy women with recurrent abscesses and a review of the literature.

Authors:  M Weischer; A Friis-Møller; A Bremmelgaard
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.